Anthony B. Costales

Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia

Anthony B. Costales, Kathleen M. Schmeler, Russell R. Broaddus et al. · Gynecologic Oncology · 2014 · 49 citations · Full text

Medicine, Gynecology, Oncology +14

Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix

Anthony B. Costales, Andrea Milbourne, Helen Rhodes et al. · Gynecologic Oncology · 2013 · 44 citations · Full text

Medicine, Oncology, Surgery +14

<i>Is it equivalent?</i> Evaluation of the clinical activity of single agent Lipodox® compared to single agent Doxil® in ovarian cancer treatment

Judith A. Smith, Anthony B. Costales, Mona Jaffari et al. · Journal of Oncology Pharmacy Practice · 2015 · 37 citations

Medicine, Oncology, Pharmacology +17

Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Laura Chambers, Julia Chalif, Meng Yao et al. · Gynecologic Oncology · 2021 · 31 citations

Medicine, Oncology, Surgery +17

Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer

Molly Morton, Laura Chambers, Anthony B. Costales et al. · Gynecologic Oncology · 2020 · 20 citations · Full text

Medicine, Oncology, Surgery +17